Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,707,000 | 4,305,000 | 4,123,000 | 4,132,000 | 3,874,000 |
| Marketable Securities | 79,000 | 86,000 | 84,000 | 81,000 | 84,000 |
| Inventories | 5,947,000 | 6,776,000 | 5,959,000 | 5,678,000 | 5,476,000 |
| Other current assets | 8,442,000 | 9,823,000 | 8,062,000 | 7,633,000 | 7,163,000 |
| TOTAL | $19,491,000 | $20,990,000 | $18,228,000 | $17,524,000 | $16,927,000 |
| Non-Current Assets | |||||
| PPE Net | 11,314,000 | 11,700,000 | 11,408,000 | 11,292,000 | 11,058,000 |
| Intangibles | 41,517,000 | 43,501,000 | 27,160,000 | 26,829,000 | 22,991,000 |
| Other Non-Current Assets | 7,370,000 | 7,054,000 | 6,836,000 | 6,720,000 | 7,090,000 |
| TOTAL | $60,201,000 | $62,255,000 | $45,404,000 | $44,841,000 | $41,139,000 |
| Total Assets | $79,692,000 | $83,245,000 | $63,632,000 | $62,365,000 | $58,066,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,678,000 | N/A | N/A | N/A | 5,769,000 |
| Accounts payable and accrued liabilities | 4,144,000 | 14,737,000 | 13,385,000 | 13,424,000 | 3,645,000 |
| Other current liabilities | 755,000 | 838,000 | 816,000 | 830,000 | 837,000 |
| TOTAL | $24,050,000 | $25,514,000 | $25,779,000 | $24,460,000 | $22,491,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,580,000 | N/A | N/A | N/A | 20,227,000 |
| Other Non-Current Liabilities | 2,909,000 | 29,469,000 | 34,300,000 | 34,010,000 | 11,145,000 |
| TOTAL | $37,285,000 | $39,671,000 | $34,886,000 | $34,534,000 | $31,903,000 |
| Total Liabilities | $61,335,000 | $65,185,000 | $60,665,000 | $58,994,000 | $54,394,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,346,000 | 1,345,000 | 1,345,000 | 1,345,000 | 1,345,000 |
| Retained earnings | 4,530,000 | 5,265,000 | -2,804,000 | -2,438,000 | -2,137,000 |
| Other shareholders' equity | 2,355,000 | 1,997,000 | 1,916,000 | 1,956,000 | 2,061,000 |
| TOTAL | $11,405,000 | $11,772,000 | $3,614,000 | $4,014,000 | $4,360,000 |
| Total Liabilities And Equity | $72,740,000 | $76,957,000 | $64,279,000 | $63,008,000 | $58,754,000 |